Literature DB >> 11747904

The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice.

A Al-Hayani1, K N Wease, R A Ross, R G Pertwee, S N Davies.   

Abstract

We have previously reported that the synthetic cannabinoid receptor agonist WIN55,212-2 causes a selective reduction in paired-pulse depression of population spikes in the CA1 region of the rat hippocampal slice. This effect is consistent with the observation that activation of cannabinoid receptors inhibits GABA release in the hippocampus. We have now investigated the actions of the putative endogenous cannabinoids 2-arachidonoyl-glycerol (2-AG) and anandamide in this system. 2-AG mimicked the effect of WIN55,212-2 by selectively reducing paired-pulse depression at concentrations of 1-30 microM. In contrast, anandamide caused a selective increase in paired-pulse depression at concentrations of 1-30 microM. This effect was mimicked by the vanilloid receptor agonists capsaicin and resiniferatoxin, and blocked by the vanilloid receptor antagonist capsazepine, but not by the cannabinoid receptor antagonist AM281. These results are the first to demonstrate a clear functional vanilloid receptor-mediated effect in the hippocampus, and further, that anandamide but not 2-AG acts at these receptors to increase paired-pulse depression of population spikes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747904     DOI: 10.1016/s0028-3908(01)00145-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  32 in total

1.  TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons.

Authors:  Helen E Gibson; Jeffrey G Edwards; Rachel S Page; Matthew J Van Hook; Julie A Kauer
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

2.  Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats.

Authors:  Thibaut R Pardo-García; Nadira Yusif-Rodriguez; Guillermo Yudowski; Carmen S Maldonado-Vlaar
Journal:  Neurosci Lett       Date:  2020-05-16       Impact factor: 3.046

3.  Intrinsic sensory deprivation induced by neonatal capsaicin treatment induces changes in rat brain and behaviour of possible relevance to schizophrenia.

Authors:  Penny Newson; Ann Lynch-Frame; Rebecca Roach; Sarah Bennett; Vaughan Carr; Loris A Chahl
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

4.  Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy.

Authors:  Muthu D Bhaskaran; Bret N Smith
Journal:  Exp Neurol       Date:  2010-02-08       Impact factor: 5.330

Review 5.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

6.  Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.

Authors:  Mario van der Stelt; Marcello Trevisani; Vittorio Vellani; Luciano De Petrocellis; Aniello Schiano Moriello; Barbara Campi; Peter McNaughton; Piero Geppetti; Vincenzo Di Marzo
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

Review 7.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  A putative 'pre-nervous' endocannabinoid system in early echinoderm development.

Authors:  G A Buznikov; L A Nikitina; V V Bezuglov; M E Y Francisco; G Boysen; I N Obispo-Peak; R E Peterson; E R Weiss; H Schuel; B R S Temple; A L Morrow; J M Lauder
Journal:  Dev Neurosci       Date:  2009-11-12       Impact factor: 2.984

9.  Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro.

Authors:  Silvia Marinelli; Christopher W Vaughan; MacDonald J Christie; Mark Connor
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.